Selina M. Luger, M.D.
Professor of Medicine at the Hospital of the University of Pennsylvania
Attending Physician , Hospital of the University of Pennsylvania
Member , Abramson Cancer Center, University of Pennsylvania
Director, Outpatient Practice, Stem Cell Transplant & Hematological Malignancies, Hospital of the University of Pennsylvania
Director, Leukemia Program, Hospital of the University of Pennsylvania
Chair,Hematology-Oncology Epic Governance, Hospital of the University of Pennsylvania
Member, Epic Operations Committee, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hematology-Oncology
Perelman Center 2 West
34th and Civic Center Blvd
Philadelphia, PA 19104
Perelman Center 2 West
34th and Civic Center Blvd
Philadelphia, PA 19104
Office: 2156141847
Fax: 2156624064
Fax: 2156624064
Email:
selina.luger@uphs.upenn.edu
selina.luger@uphs.upenn.edu
Education:
A.B. (Biochemistry)
Harvard University, 1982.
M.D. (Medicine)
McGill University, 1987.
A.B. (Biochemistry)
Harvard University, 1982.
M.D. (Medicine)
McGill University, 1987.
Post-Graduate Training
Intern, Internal Medicine , Presbyterian University Hospital, Pittsburgh, 1987-1988.
Resident, Internal Medicine , Presbyterian University Hospital, Pittsburgh, 1988-1990.
Fellowship, Hematology-Oncology , University of Pennsylvania, Philadelphia, 1990-1993.
Intern, Internal Medicine , Presbyterian University Hospital, Pittsburgh, 1987-1988.
Resident, Internal Medicine , Presbyterian University Hospital, Pittsburgh, 1988-1990.
Fellowship, Hematology-Oncology , University of Pennsylvania, Philadelphia, 1990-1993.
Certifications
Royal College of Physicians & Surgeons of Canada, 1990.
ABIM/Internal Medicine, 1990.
ABIM/Medical Oncology, 1993.
ABIM/Hematology, 2005.
Permanent linkRoyal College of Physicians & Surgeons of Canada, 1990.
ABIM/Internal Medicine, 1990.
ABIM/Medical Oncology, 1993.
ABIM/Hematology, 2005.
Description of Research Expertise
Leukemia, myelodysplastic syndrome, myeloproliferative disordersMDS, AML, CML, ALL
Description of Clinical Expertise
hematologic malignancies, leukemia, AML, ALL, CML, myelodysplastic syndrome, MDS, myeloproliferative disorders, stem cell transplantation, bone marrow transplantSelected Publications
Nazha, A. Cook, R. Vogl, D T. Mangan, P A. Gardler, M. Hummel, K. Cunningham, K. Luger, S M. Porter, D L. Schuster, S. O'Doherty, U. Siegel, D. Stadtmauer, E A.: Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen. Bone Marrow Transplantation 46(1): 59-63, Jan 2011.Luger, Selina M.: Treating the elderly patient with acute myelogenous leukemia. Hematology 2010: 62-9, December 2010.
Cripe, Larry D. Uno, Hajime. Paietta, Elisabeth M. Litzow, Mark R. Ketterling, Rhett P. Bennett, John M. Rowe, Jacob M. Lazarus, Hillard M. Luger, Selina. Tallman, Martin S.: Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood 116(20): 4077-85, Nov 18 2010.
Ochs, Rachel C. Gormley, Rachel H. Luger, Selina. Bagg, Adam.: Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence. Journal of Clinical Oncology 28(29): e550-3, Oct 10 2010.
Cortes, Jorge. Moore, Joseph O. Maziarz, Richard T. Wetzler, Meir. Craig, Michael. Matous, Jeffrey. Luger, Selina. Dey, Bimalangshu R. Schiller, Gary J. Pham, Dat. Abboud, Camille N. Krishnamurthy, Muthuswamy. Brown, Archie Jr. Laadem, Abderrahmane. Seiter, Karen.: Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study. Journal of Clinical Oncology 28(27): 4207-13, Sep 20 2010.
Mato, Anthony R. Luger, Selina M. Heitjan, Daniel F. Mikkelsen, Mark E. Olson, Erin. Ujjani, Chaitra. Jacobs, Samantha. Miltiades, Andrea N. Shah, Payal. Schuster, Stephen J. Carroll, Martin. Chauffe, Ann Duskin. Fuchs, Barry D.: Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biology & Therapy 9(8): 585-9, Apr 2010.
Litzow, Mark R. Tarima, Sergey. Perez, Waleska S. Bolwell, Brian J. Cairo, Mitchell S. Camitta, Bruce M. Cutler, Corey S. de Lima, Marcos. Dipersio, John F. Gale, Robert Peter. Keating, Armand. Lazarus, Hillard M. Luger, Selina. Marks, David I. Maziarz, Richard T. McCarthy, Philip L. Pasquini, Marcelo C. Phillips, Gordon L. Rizzo, J Douglas. Sierra, Jorge. Tallman, Martin S. Weisdorf, Daniel J.: Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115(9): 1850-7, Mar 4 2010.
Marks, David I. Paietta, Elisabeth M. Moorman, Anthony V. Richards, Susan M. Buck, Georgina. DeWald, Gordon. Ferrando, Adolfo. Fielding, Adele K. Goldstone, Anthony H. Ketterling, Rhett P. Litzow, Mark R. Luger, Selina M. McMillan, Andrew K. Mansour, Marc R. Rowe, Jacob M. Tallman, Martin S. Lazarus, Hillard M.: T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood 114(25): 5136-45, Dec 10 2009.
Perl, Alexander E. Kasner, Margaret T. Tsai, Donald E. Vogl, Dan T. Loren, Alison W. Schuster, Stephen J. Porter, David L. Stadtmauer, Edward A. Goldstein, Steven C. Frey, Noelle V. Nasta, Sunita D. Hexner, Elizabeth O. Dierov, Jamil K. Swider, Cezary R. Bagg, Adam. Gewirtz, Alan M. Carroll, Martin. Luger, Selina M.: A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. Clinical Cancer Research 15(21): 6732-9, Nov 1 2009.
Fernandez, Hugo F. Sun, Zhuoxin. Yao, Xiaopan. Litzow, Mark R. Luger, Selina M. Paietta, Elisabeth M. Racevskis, Janis. Dewald, Gordon W. Ketterling, Rhett P. Bennett, John M. Rowe, Jacob M. Lazarus, Hillard M. Tallman, Martin S.: Anthracycline dose intensification in acute myeloid leukemia. New England Journal of Medicine 361(13): 1249-59, Sep 24 2009.
